Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 11: Rain popping up on the DualDoppler 5000 radar. When it moves out and the newest track for Hurricane Rafael
Program
Thursday on WRAL at 6: Violence against healthcare workers is surging! WRAL Investigates why the people caring for us fear for their lives at work
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Otr Acquisition Corp Cl A
(NQ:
OTRA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 19, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
9.650 (2)
Ask (Size)
10.33 (10)
Prev. Close
9.910
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics
May 20, 2022
From
Comera Life Sciences Holdings, Inc.
Via
Business Wire
38 Stocks Moving In Thursday's Mid-Day Session
May 19, 2022
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for...
Via
Benzinga
Performance
More News
Read More
Why Is OTR Acquisition (OTRA) Stock Up Today?
May 13, 2022
Via
InvestorPlace
Why OTR Acquisition Shares Are Soaring Today
May 13, 2022
Via
Benzinga
71 Biggest Movers From Yesterday
May 20, 2022
Via
Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
May 18, 2022
Via
Benzinga
76 Biggest Movers From Yesterday
May 19, 2022
Via
Benzinga
What's Going On With OTR Acquisition Stock Today?
May 18, 2022
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; Target Earnings Miss Views
May 18, 2022
Via
Benzinga
MULN Stock Pops 20% After Mullen Automotive Releases Preliminary Q2 Summary
May 13, 2022
Via
InvestorPlace
23 Stocks Moving in Friday's Pre-Market Session
May 13, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 13, 2022
Via
InvestorPlace
99 Biggest Movers From Yesterday
May 12, 2022
Via
Benzinga
103 Biggest Movers From Yesterday
May 11, 2022
Via
Benzinga
90 Biggest Movers From Yesterday
May 10, 2022
Via
Benzinga
10 Financials Stocks Moving In Monday's Intraday Session
May 09, 2022
Via
Benzinga
Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation
May 09, 2022
From
Comera Life Sciences, Inc.
Via
Business Wire
Stocks That Hit 52-Week Highs On Monday
May 02, 2022
Via
Benzinga
Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo
April 27, 2022
From
Comera Life Sciences, Inc.
Via
Business Wire
Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration
April 19, 2022
From
Comera Life Sciences, Inc.
Via
Business Wire
Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
April 18, 2022
From
OTR Acquisition Corp.
Via
Business Wire
OTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
February 04, 2022
From
OTR Acquisition Corp.
Via
Business Wire
Biologic Medicines-Focused Comera Life Sciences Turns To SPAC For NASDAQ Debut
January 31, 2022
Via
Benzinga
Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.
January 31, 2022
From
Comera Life Sciences
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.